These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25553577)

  • 1. Predicting and preventing vascular complications following percutaneous coronary intervention in women.
    Kim M; Chu A; Khan Y; Malik S
    Expert Rev Cardiovasc Ther; 2015 Feb; 13(2):163-72. PubMed ID: 25553577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry.
    Ahmed B; Piper WD; Malenka D; VerLee P; Robb J; Ryan T; Herne M; Phillips W; Dauerman HL
    Circ Cardiovasc Interv; 2009 Oct; 2(5):423-9. PubMed ID: 20031752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transradial and transulnar access for percutaneous coronary interventions.
    Kedev S
    Turk Kardiyol Dern Ars; 2011 Jun; 39(4):332-40. PubMed ID: 21646838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation in transradial percutaneous coronary intervention.
    Appleton DL; Cooke RH; Rao SV; Jovin IS
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):237-42. PubMed ID: 23766092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: an evaluation of the RISK-PCI data.
    Mrdovic I; Savic L; Asanin M; Cvetinovic N; Brdar N; Djuricic N; Stepkovic M; Marinkovic J; Perunicic J
    Can J Cardiol; 2013 Sep; 29(9):1097-103. PubMed ID: 23462375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis.
    Kikkert WJ; Delewi R; Ouweneel DM; van Nes SH; Vis MM; Baan J; Koch KT; Dangas GD; Mehran R; de Winter RJ; Peters RJ; Piek JJ; Tijssen JG; Henriques JP
    JACC Cardiovasc Interv; 2014 Jun; 7(6):622-30. PubMed ID: 24835321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies.
    Patti G; Cannon CP; Murphy SA; Mega S; Pasceri V; Briguori C; Colombo A; Yun KH; Jeong MH; Kim JS; Choi D; Bozbas H; Kinoshita M; Fukuda K; Jia XW; Hara H; Cay S; Di Sciascio G
    Circulation; 2011 Apr; 123(15):1622-32. PubMed ID: 21464051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence.
    Lee MS; Wolfe M; Stone GW
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1149-52. PubMed ID: 24262614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry.
    Rao SV; McCoy LA; Spertus JA; Krone RJ; Singh M; Fitzgerald S; Peterson ED
    JACC Cardiovasc Interv; 2013 Sep; 6(9):897-904. PubMed ID: 24050858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRUSADE bleeding risk score validation for ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Ariza-Solé A; Sánchez-Elvira G; Sánchez-Salado JC; Lorente-Tordera V; Salazar-Mendiguchía J; Sánchez-Prieto R; Romaguera-Torres R; Ferreiro-Gutiérrez JL; Gómez-Hospital JA; Cequier-Fillat A
    Thromb Res; 2013; 132(6):652-8. PubMed ID: 24112751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women, bleeding, and coronary intervention.
    Ahmed B; Dauerman HL
    Circulation; 2013 Feb; 127(5):641-9. PubMed ID: 23381962
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study.
    Guagliumi G; Capodanno D; Saia F; Musumeci G; Tarantini G; Garbo R; Tumminello G; Sirbu V; Coccato M; Fineschi M; Trani C; De Benedictis M; Limbruno U; De Luca L; Niccoli G; Bezerra H; Ladich E; Costa M; Biondi Zoccai G; Virmani R;
    JACC Cardiovasc Interv; 2014 Sep; 7(9):958-68. PubMed ID: 25129664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.
    Bagai A; Wang Y; Wang TY; Curtis JP; Gurm HS; Shah B; Cheema AN; Peterson ED; Saucedo JF; Granger CB; Roe MT; Bhatt DL; McNamara RL; Alexander KP
    Circ Cardiovasc Interv; 2014 Aug; 7(4):585-93. PubMed ID: 25097196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.
    Zemánek D; Branny M; Martinkovičová L; Hájek P; Malý M; Tesař D; Tomašov P; Veselka J
    Int J Cardiol; 2013 Oct; 168(3):2494-7. PubMed ID: 23597577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhagic and vascular complications after percutaneous coronary intervention with adjunctive abciximab.
    Cote AV; Berger PB; Holmes DR; Scott CG; Bell MR
    Mayo Clin Proc; 2001 Sep; 76(9):890-6. PubMed ID: 11560299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
    Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
    Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the optimal cardiac troponin T threshold for predicting death caused by periprocedural myocardial infarction after percutaneous coronary intervention.
    Herrmann J; Lennon RJ; Jaffe AS; Holmes DR; Rihal CS; Prasad A
    Circ Cardiovasc Interv; 2014 Aug; 7(4):533-42. PubMed ID: 25052010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative percutaneous coronary intervention in patients undergoing open thoracoabdominal and descending thoracic aneurysm repair.
    Girardi LN; Rabotnikov Y; Avgerinos DV
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):163-8. PubMed ID: 24176270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention.
    Park DW; Kim YH; Yun SC; Ahn JM; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Eur Heart J; 2013 Jun; 34(22):1662-9. PubMed ID: 23404537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012).
    Feldman DN; Swaminathan RV; Kaltenbach LA; Baklanov DV; Kim LK; Wong SC; Minutello RM; Messenger JC; Moussa I; Garratt KN; Piana RN; Hillegass WB; Cohen MG; Gilchrist IC; Rao SV
    Circulation; 2013 Jun; 127(23):2295-306. PubMed ID: 23753843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.